Preventing hospitalisation and early death from chronic heart failure in primary care: a randomised controlled trial of pharmacist led medication review

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN70118765

Enrollment

2400

Registered

2006-07-06

Start date

2004-05-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic heart failure Circulatory System Chronic heart failure

Interventions

Practices in the control group, in common with intervention group, receive a complete disease register for patients with a diagnosis of chronic heart failure due to left ventricular systolic dysfuncti

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Consenting practices 2. Patients with confirmed left ventricular systolic dysfunction (LSVD) providing written consent

Exclusion criteria

Exclusion criteria: 1. Non LVSD 2. Not chronic heart failure 3. Renal failure requiring dialysis 4. Patient under enhanced form of Primary Care

Design outcomes

Primary

Measure	Time frame
Death or heart failure hospitalisations	—

Secondary

Measure	Time frame
Survival times until occurrence of first heart failure hospitalisation or death	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 27, 2026